Transderm

transdermHIGHLIGHTS

FDA cleared as alternative to injections.

New Internationally Patented proprietary

Dermoelectroporation Technology.

Non invasive and comfortable.

WHAT IS ULTRAPEEL II TRANSMDERM MESOSYSTEM

Ultrapeel   II plus Transderm ® Meso® System is a powered drug-delivery system that has been FDA approved for the “local administration of ionic drug solutions into the body for medical purposes and can be used as an alternative to injections”.

Ultrapeel II Transderm® MesoSystem uses Dermoelectroporation Technology to deliver any active ingredient into the body and when connected to Ultrapeel microdermabrader allows a very efficient transdermal delivery of products.

Macromolecules (greater than 15.000 Dalton) previously not transdermally deliverable by traditional Ionthophoresis are now successfully deliverable due this outstanding Dermoelectroporation Technology.

Patients will enjoy treatments with UltrapeelII plus Transderm Meso® System due to the very high comfortable sessions.

BENEFITS TO PATIENTS

• ASTONISHING RESULTS FROM THE 1st SESSION

• COMFORTABLE TREATMENTS

• NO DOWNTIME OR SOCIAL LIFE RESTRICTION OF ANY SORT

• NO IRRITATIONS, BURNINGS OR INFLAMMATIONS

• NO TRAUMA FROM INJECTIONS

• FASTER OUTCOMES DUE TWO ULTRAPEEL

APPLICATIONS

• Cellulite treatments
• Skin Rejuvenation treatments
• Wrinkles treatments
• Fat Deposits treatments
• Pre laser treatments
• Pre and post plastic surgery sessions
• Skin Whitening treatments
• Aesthetic applications

DELIVERABLE PRODUCTS

• Type A Botulinum Toxine (Wrinkles Treatment)
• Phosphatidylcoline (Break down fat)
• Hyaluronic Acid ( Hydrating)
• Aminophylline (Cellulite Treatment)
• Grow Factors (Anti-aging)
• Amino Acids (Anti-aging)
• L-Carnitine (Fat Burner)
• Lidocaine (Anaesthetic)
• Collagen (Anti-aging)
• Vitamins (Whitening)

Leave a comment